Evidence map›Paper›PMID 32481537›Full record

ArticleCancers2020

Assessment of Periprostatic and Subcutaneous Adipose Tissue Lipolysis and Adipocyte Size from Men with Localized Prostate Cancer.

Dushan Miladinovic, Thomas Cusick, Kate L Mahon, Anne-Maree Haynes, Colin H Cortie, Barbara J Meyer, Phillip D Stricker, Gary A Wittert, Lisa M Butler, Lisa G Horvath and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Nutrients · 2024
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Prognostic Value of CT-Attenuation andJournal of personalized medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Dushan MiladinovicDiscipline of Physiology, School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2006, Australia.
Thomas CusickCancer Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia.
Kate L MahonCancer Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia.
Anne-Maree HaynesCancer Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia.
Colin H CortieSchool of Medicine, Lipid Research Centre, Molecular Horizons, University of Wollongong, Wollongong, NSW 2522, Australia.
Barbara J MeyerSchool of Medicine, Lipid Research Centre, Molecular Horizons, University of Wollongong, Wollongong, NSW 2522, Australia.ORCID 0000-0001-7962-7890
Phillip D StrickerCancer Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia.
Gary A WittertSouth Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia.
Lisa M ButlerSouth Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia.ORCID 0000-0003-2698-3220
Lisa G HorvathCancer Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia.
Andrew J HoyDiscipline of Physiology, School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2006, Australia.ORCID 0000-0003-3922-1137
The University of Sydney · AUGarvan Institute of Medical Research · AUSouth Australian Health and Medical Research Institute · AUUniversity of Wollongong · AU

Funding

Cancer Council South Australia Beat Cancer Project ButlerCancer Institute NSW APCRC-NSWDepartment of Health and Ageing, Australian Government APCRC-NSWMovember Foundation MRTA3Prostate Cancer Foundation of Australia MRTA3Sydney Medical School Foundation HoyUniversity of Sydney Robinson Fellowship
6 · The paper itself

Abstract

The prostate is surrounded by periprostatic adipose tissue (PPAT), the thickness of which has been associated with more aggressive prostate cancer (PCa). There are limited data regarding the functional characteristics of PPAT, how it compares to subcutaneous adipose tissue (SAT), and whether in a setting of localized PCa, these traits are altered by obesity or disease aggressiveness. PPAT and SAT were collected from 60 men (age: 42-78 years, BMI: 21.3-35.6 kg/m

Indexed as

lipolysislocalized prostate cancerperiprostatic adipose tissueprostate cancersubcutaneous adipose tissue

Identifiers

PMID32481537
PMCPMC7352157
OpenAlexW3030676017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.